North America HLA Typing Transplant Diagnostics Services Market | CAGR of over 8.8% | Top Company Players :- Proimmune, Creative Biolabs, Histogenetics LLC, The UCLA Immunogenetics Center, Admera Health, Quick Biology 2025

Industry Highlights:

North America HLA typing transplant diagnostics services market is expected to reach USD 474.83 million by 2025, from USD 242.82 million in 2017 growing at a CAGR of 8.8% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors driving the growth of this market are technological advancements in HLA typing, increasing number of solid organ and stem cell transplantation procedures, risen research grants, funds, and public-private investments are boosting the growth of the North America HLA typing transplant diagnostics services market. On the other hand, weak reimbursements for organ donation and transplantation procedures, expensive NGS and PCR-based devices may hinder the growth of the market.

Get a Sample Copy of this Report @ https://marketprognosis.com/sample-request/11689

Top Market Player’s
The key market players for North America HLA typing transplant diagnostics services market are listed below:
• Proimmune Ltd.
• Creative Biolabs
• Histogenetics LLC
• The UCLA Immunogenetics Center
• Admera Health, Quick Biology
• New York Blood Center
• The Sequencing Center
• BloodCenter of Wisconsin
• Laboratory Corporation of America Holdings
• One Lambda (Thermo Fischer Scientific, InC.)

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Ask For Discount @ https://marketprognosis.com/discount-request/11689

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Market Segments
The market is further segmented into:
• Technology
• End-User

The North America HLA typing transplant diagnostics services market is segmented based on technology into polymerase chain reaction (PCR), and next-generation sequencing (NGS). In 2018, polymerase chain reaction (PCR) segment is expected to dominate the North America HLA typing transplant diagnostics services market with 52.0% market share and is expected to reach USD 242.58 million by 2025, with a CAGR of 8.6% in the forecast period 2018 to 2025. However, Next-Generation Sequencing (NGS) is expected to grow at the highest CAGR of 9.1% in the forecast period, and is expected to reach USD 232.25 million in 2025 from USD 116.16 million in 2017.

The polymerase chain reaction (PCR) is further sub segmented on the basis of techniques into PCR-SSP (Sequence-Specific Primer), PCR SSOP (Sequence-Specific Oligonucleotide), and PCR-SBT (Sequencing Based Typing). In 2018, PCR-SSP (Sequence-Specific Primer) segment is expected to dominate the North America HLA typing transplant diagnostics services market with 43.3% market share and is expected to reach USD 199.66 million by 2025, with the CAGR of 8.4% in the forecast period 2018 to 2025. However, PCR-SBT (Sequencing Based Typing) segment is expected to grow at the highest CAGR of 9.4% in the forecast period, and is expected to reach USD 94.48 million in 2025 from USD 46.32 million in 2017.

The North America HLA typing transplant diagnostics services market is segmented on the basis of end users into hospitals, transplant centers, specialty clinics, and academic institutes. In 2018, hospitals segment is expected to dominate the North America HLA typing transplant diagnostics services market with 37.8% market share and is expected to reach USD 185.24 million by 2025, with the highest CAGR of 9.3% in the forecast period 2018 to 2025.
Based on geography, the market is segmented into:
• U.S.
• Canada
• Mexico

Enquiry Before Buying @ https://marketprognosis.com/enquiry/11689

About Us
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact
ProgMark Pvt Ltd,
Thane - 421501
India. Contact- +1 973 241 5193
Email- sales@marketprognosis.com

This release was published on openPR.